Correspondence on "Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment" by Felson et al

被引:1
|
作者
Ferreira, Ricardo J. O. [1 ,2 ,3 ]
Welsing, Paco M. J. [4 ]
Jacobs, Johannes W. G. [4 ]
Gossec, Laure [5 ,6 ]
Ndosi, Mwidimi [7 ]
Machado, Pedro M. [8 ,9 ]
van Der Heijde, Desiree [10 ]
da Silva, Jose A. P. [11 ,12 ]
机构
[1] Univ Coimbra, Coimbra, Portugal
[2] Ctr Hosp, Coimbra, Portugal
[3] Hlth Sci Res Unit Nursing, Coimbra, Portugal
[4] Univ Med Ctr Utrecht, Utrecht, Netherlands
[5] Sorbonne Univ, Assistance Publ Hop Paris, Pitie Salpetriere Hosp, Inst Pierre Louis dEpidemiol & Sante Publ, Paris, France
[6] Sorbonne Univ, Assistance Publ Hop Paris, Inst Natl Sante & Rech Med, Paris, France
[7] Univ West England, Bristol, Avon, England
[8] UCL, London North West Univ, Northwick Pk Hosp, Hlthcare Natl Hlth Serv Trust, London, England
[9] UCL, London North West Univ, Univ Coll London Hosp NHS Fdn Trust, Hlthcare Natl Hlth Serv Trust, London, England
[10] Leiden Univ, Med Ctr, Leiden, Netherlands
[11] Univ Coimbra, Coimbra, Portugal
[12] Ctr Hosp, Coimbra, Portugal
关键词
CLINICAL-PRACTICE;
D O I
10.1002/acr2.11402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:271 / 272
页数:2
相关论文
共 35 条
  • [21] Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients
    Yoshii, Ichiro
    Chijiwa, Tatsumi
    Sawada, Naoya
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (11) : 1955 - 1961
  • [22] Pain catastrophizing hinders Disease Activity Score 28-erythrocyte sedimentation rate remission of rheumatoid arthritis in patients with normal C-reactive protein levels
    Yoshida, Tamami
    Hashimoto, Motomu
    Horiguchi, Go
    Murakami, Kosaku
    Murata, Koichi
    Nishitani, Kohei
    Watanabe, Ryu
    Yamamoto, Wataru
    Tanaka, Masao
    Morinobu, Akio
    Ito, Hiromu
    Matsuda, Shuichi
    Uehara, Ritei
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1520 - 1529
  • [23] Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
    Wells, G.
    Becker, J-C
    Teng, J.
    Dougados, M.
    Schiff, M.
    Smolen, J.
    Aletaha, D.
    van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 954 - 960
  • [24] LONG-TERM (FOUR YEAR) 28-JOINT COUNT DISEASE ACTIVITY SCORE (C-REACTIVE PROTEIN) REMISSION AND IMPROVEMENTS IN SKIN DISEASE WITH APREMILAST: PHASE III RESULTS FROM PALACE3
    Edwards, Christopher
    Blanco, Francisco J.
    Crowley, Jeffrey
    Paris, Maria
    Delev, Nikolay
    Teng, Lichen
    Birbara, Charles A.
    RHEUMATOLOGY, 2018, 57
  • [25] Time to score quantitative rheumatoid arthritis measures: 28-joint count, disease activity score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores
    Yazici, Yusuf
    Bergman, Martin
    Pincus, Theodore
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (04) : 603 - 609
  • [26] Measures of Rheumatoid Arthritis Disease Activity Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score Without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA)
    Anderson, Jaclyn K.
    Zimmerman, Lani
    Caplan, Liron
    Michaud, Kaleb
    ARTHRITIS CARE & RESEARCH, 2011, 63 : S14 - S36
  • [27] Correlation of a Multi-Biomarker Disease Activity Response Assessment to Disease Activity Score 28 (C-Reactive Protein) Response Assessment and Omeract Ramris Scores in a Placebo-Controlled Rheumatoid Arthritis Clinical Trial with Abatacept (ASSET).
    Haney, D. J.
    Cavet, G.
    Durez, P.
    Alten, R.
    Burmester, G. R.
    Tak, P. P.
    Catrina, Anka I.
    Gaillez, C.
    Le Bars, M.
    Connolly, S.
    Townsend, R.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S913 - S913
  • [28] Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio
    Yang, Wei-ming
    Zhang, Wei-heng
    Ying, Hou-qun
    Xu, Yan-mei
    Zhang, Jing
    Min, Qing-hua
    Huang, Bo
    Lin, Jin
    Chen, Juan-juan
    Wang, Xiao-zhong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 : 293 - 298
  • [29] Response to: 'Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry' by Favalli et al
    Fleischmann, Roy
    Bananis, Eustratios
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01)
  • [30] Serum Vitamin D Levels, Disease Activity Score-28 for Rheumatoid Arthritis with C-Reactive Protein (DAS28-CRP), and Cardiac Remodeling Determined by Ventricular Dimensions and Left Atrium Diameter in Patients with Rheumatoid Arthritis: A Prospective Observational Study
    Batista, Andrea A. P.
    Lazzarin, Taline
    Pereira, Filipe W. L.
    Baccaro, Antonio
    Rocha, Oswaldo M.
    Narimatsu, Karina L.
    Souza, Juli T.
    Modesto, Pamela N.
    Bazan, Silmeia Garcia Zanati
    Tanni, Suzana E.
    Okoshi, Marina P.
    Polegato, Bertha F.
    Paiva, Sergio A. R.
    Zornoff, Leonardo
    Minicucci, Marcos F.
    Azevedo, Paula S.
    MEDICAL SCIENCE MONITOR, 2023, 29